Activation antigen expression on human T cells. I. Analysis by two- colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue

Clinical and Experimental Immunology

Volumn 105, Issue 1, 1996, Pages 176-182

  Amlot, P L ^a   Tahami, F ^a   Chinn, D ^a   Rawlings, E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

activation; lymphoid tissue; phenotype; T lymphocyte

Indexed keywords

CD7 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HLA DR3 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHILD; FEMALE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; LYMPHOID TISSUE; MALE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

EID: 0030054966     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-722.x     Document Type: Article

References (40)

1. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science 1989; 243:355-61.
2. Sharon M, Siegel JP, Tosato G, Yodoi J, Gerrard TL, Leonard WJ. The human interleukin 2 receptor β chain (p70). Direct identification, partial purification, and pattern of expression on peripheral blood mononuclear cells. J Exp Med 1988; 167:1265.
3. Greene WC, Leonard WJ. The human IL2 receptor. Ann Rev Immunol 1986; 4:69.
4. Jackson AL, Matsumoto H, Janszen M, Maino V, Blidy A, Shye S. Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells. Clin Immunol Immunopathol 1990; 54:126.
5. Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. J Exp Med 1990; 171:1509-26.
6. Ohashi Y, Takeshita T, Nagata K, Mori S, Sugamura K. Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. J Immunol 1989; 143:3548-55.
7. + lymphocytes expressing CD45RO and CD45RA. J Immunol Methods 1993; 163:173-9.
8. Seron D, Alexopoulos E, Raftery MJ, Hartley RB, Cameron JS. Diagnosis of rejection in renal allograft biopsies using the presence of activated and proliferating cells. Transplantation 1989; 47:811-6.
9. + alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium. Eur J Immunol 1993; 23:505-10.
10. Wijngaard PLJ, Tuijman WB, Meyling FHJG et al. Endomyocardial biopsies after heart transplantation. The presence of markers indicative of activation. Transplantation 1993; 55:103-10.
11. Siegel JP, Sharon M, Smith PL, Leonard WJ. The IL-2 receptor β chain (p70): role in mediating signals for LAK, NK and proliferative activities. Science 1987; 238:75-78.
12. Bich-Thuy LT, Dukovich M, Peffer NJ, Fauci AS, Kehrl JH, Greene WC. Direct activation of human resting T cells by IL2: the role of an IL2 receptor distinct from the Tac protein. J Immunol 1987; 139:1550.
13. Reed MH, Shapiro ME, Milford EL, Carpenter CB, Kirkman RL. Interleukin 2 receptor expression on peripheral blood lymphocytes in association with renal allograft rejection. Transplantation 1989; 48:361-6.
14. Ramos EL, Milford EL, Kirkman RL et al. Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2 receptor antibody. Transplantation 1989; 48:415-20.
15. Kirkman RL, Shapiro ME, Carpenter CB et al. A randomised prospective trial of anti-Tac monoclonal antibody in human renal transplantation. Transplantation 1991; 51:107-13.
16. Cotner T, Williams JM, Christenson L, Shapiro HM, Strom TB, Strominger JL. Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med 1983; 157:461-72.
17. Janszen M, Buck D, Maino VC. Functional and molecular properties of CD25 monoclonal antibodies. In: Knapp W, Dorken B, Gilks WR et al., eds. Leukocyte typing IV. Oxford: Oxford University Press, 1989:403-6.
18. Janossy G, Amlot PL. Immunofluorescence and immunohistochemistry. In: Klaus GGB, ed. Lymphocytes - a practical approach. Oxford: IRL Press Ltd., 1987:67-108.
19. Barclay AN, Birkeland ML, Brown MH et al. The leukocyte antigen facts book. London: Academic Press Ltd, 1993.
20. Ishii N, Takeshita T, Kimura Y et al. Expression of the IL-2 receptor γ chain on various populations in human peripheral blood. Int Immunol 1994; 6:1273-7.
21. Amlot PL, Rawlings E, Fernando ON et al. Prolonged action of a chimeric IL-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. Transplantation 1995; 60:748-56.
22. Poncelet P, Poinas G, Corbeau P et al. Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease. Res Immunol 1991; 142:291-8.
23. Poncelet P, Carayon P. Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J Immunol Methods 1985; 85:65-74.
24. Lenkei R, Andersson B. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J Immunol Methods 1995; 183:267-77.
25. Beverley PCL. Is T-cell memory maintained by crossreactive stimulation? [Review]. Immunol Today 1990; 11:203-5.
26. + T cells synergize in response to alloantigens. Eur J Immunol 1991; 21:2517-22.
27. Mattern T, Scholz W, Feller AC, Flad H-D, Ulmer AJ. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes. Scand J Immunol 1991; 33:737-48.
28. Stein H, Schwarting R, Niedobitek G. A2 cluster report: CD26. In: Knapp W, Dorken B, Gilks WR et al., eds. Leukocyte typing IV. Oxford: Oxford University Press, 1989:412-8.
29. Dang NH, Torimoto Y, Shimamura K, Tanaka T, Daley JF, Schlossman SF. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J Immunol 1991; 147:2825-32.
30. Hintzen RQ, de Jong R, Lens MAS, van Lier RAW. CD27: marker and mediator of T-cell activation? Immunol Today 1994; 15:307-11.
31. Schwarting R, Niedobitek G, Stein H. A4 cluster report: CD69. In: Knapp W, Dorken B, Gilks WR et al., eds. Leukocyte typing IV. Oxford: Oxford University Press, 1989:428-45.
32. Vandenberghe P, Verwilghen F, Van Vaeck F, Ceuppens JL. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism. Immunology 1993; 78:210-7.
33. Cantrell DA, Smith KA. Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med 1983; 158:1895-911.
34. Depper JM, Leonard WJ, Kronke M et al. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen. J Immunol 1984; 133:3054-61.
35. Salmon M, Pilling D, Borthwick N et al. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 1994; 24:892-9.
36. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: a glycoprotein in search of a function, Immunol Today 1994; 15:95-97.
37. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LWMM. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory transition. J Immunol 1993; 150:1105-21.
38. Harris DT, Schumacher MJ, Locasio J et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992; 89:10006-10.
39. Gerli R, Agea E, Muscat C et al. Activation of cord T lymphocytes III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response. Cell Immunol 1993; 148:32-47.
40. Amlot PL, Chinn D, Tahami F. Activation antigen expression on human T cells. II. Cytotoxic (CD8) cells. Clin Exp Immunol 1996; (submitted for publication).